Cargando…
Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543165/ https://www.ncbi.nlm.nih.gov/pubmed/37102614 http://dx.doi.org/10.3324/haematol.2022.282160 |
| _version_ | 1785114239391760384 |
|---|---|
| author | Rausch, Johanna Dzama, Margarita M. Dolgikh, Nadezda Stiller, Hanna L. Bohl, Stephan R. Lahrmann, Catharina Kunz, Kerstin Kessler, Linda Echchannaoui, Hakim Chen, Chun-Wei Kindler, Thomas Döhner, Konstanze Burrows, Francis Theobald, Matthias Sasca, Daniel Kühn, Michael W. M. |
| author_facet | Rausch, Johanna Dzama, Margarita M. Dolgikh, Nadezda Stiller, Hanna L. Bohl, Stephan R. Lahrmann, Catharina Kunz, Kerstin Kessler, Linda Echchannaoui, Hakim Chen, Chun-Wei Kindler, Thomas Döhner, Konstanze Burrows, Francis Theobald, Matthias Sasca, Daniel Kühn, Michael W. M. |
| author_sort | Rausch, Johanna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10543165 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105431652023-10-03 Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax Rausch, Johanna Dzama, Margarita M. Dolgikh, Nadezda Stiller, Hanna L. Bohl, Stephan R. Lahrmann, Catharina Kunz, Kerstin Kessler, Linda Echchannaoui, Hakim Chen, Chun-Wei Kindler, Thomas Döhner, Konstanze Burrows, Francis Theobald, Matthias Sasca, Daniel Kühn, Michael W. M. Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-04-27 /pmc/articles/PMC10543165/ /pubmed/37102614 http://dx.doi.org/10.3324/haematol.2022.282160 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Rausch, Johanna Dzama, Margarita M. Dolgikh, Nadezda Stiller, Hanna L. Bohl, Stephan R. Lahrmann, Catharina Kunz, Kerstin Kessler, Linda Echchannaoui, Hakim Chen, Chun-Wei Kindler, Thomas Döhner, Konstanze Burrows, Francis Theobald, Matthias Sasca, Daniel Kühn, Michael W. M. Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax |
| title | Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax |
| title_full | Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax |
| title_fullStr | Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax |
| title_full_unstemmed | Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax |
| title_short | Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax |
| title_sort | menin inhibitor ziftomenib (ko-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with mll rearrangement or npm1 mutation to venetoclax |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543165/ https://www.ncbi.nlm.nih.gov/pubmed/37102614 http://dx.doi.org/10.3324/haematol.2022.282160 |
| work_keys_str_mv | AT rauschjohanna menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT dzamamargaritam menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT dolgikhnadezda menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT stillerhannal menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT bohlstephanr menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT lahrmanncatharina menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT kunzkerstin menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT kesslerlinda menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT echchannaouihakim menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT chenchunwei menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT kindlerthomas menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT dohnerkonstanze menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT burrowsfrancis menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT theobaldmatthias menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT sascadaniel menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax AT kuhnmichaelwm menininhibitorziftomenibko539synergizeswithdrugstargetingchromatinregulationorapoptosisandsensitizesacutemyeloidleukemiawithmllrearrangementornpm1mutationtovenetoclax |